HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Consumer Healthcare Inc.

https://www.prestigebrands.com/

Latest From Prestige Consumer Healthcare Inc.

US Q4 Consumer Health Earnings Preview: Supply Chain Disruption Returns, Opill Launch Waits

Attacks on shipping since November in the Red Sea lead shipping lines to re-route vessels south of Africa, spiking shipping costs. Perrigo began 2024 saying it expects sales of Opill oral contraceptive to start early in the first quarter, but now expects to start late in the quarter.

Consumer Sales & Earnings

Prestige Consumer Focused On ‘Smaller Categories’ As Larger Firms Change Industry Landscape

Larger consumer health firms are “looking to move-the-needle opportunities, which are big brands, big categories, different regions than we compete in as part of their business objective,” says CEO Ron Lombardi as PCH reports revenues down slightly from year-ago period at $286.3m.

OTC Drugs Sales & Earnings

US Q3 Consumer Health Earnings Preview: Phenylephrine Question Punctuates Quarter

Consumer health products sector’s earnings reports for July-September period are its first since FDA advisory committee unanimously voted that results of research agency presented show oral phenylephrine at OTC monograph doses is ineffective to treat nasal congestion.

Consumer Sales & Earnings

In Consumer Health Serve And Volley, Brands Holding Market Share Against Private Label

Beauty and consumer health care weren’t among the the consumer packaged goods categories showing private label market-share growth during April-June period. Consumer health industry executives see more spending on private label in some categories but without affecting their results.

Consumer Market Intelligence
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Prestige Brands, Inc.
UsernamePublicRestriction

Register